article · NEWPORT INTERNATIONAL JOURNAL OF BIOLOGICAL AND APPLIED SCIENCES
This paper reviews hematologic support strategies, specifically blood transfusions, for patients living with HIV. It highlights that HIV infection often leads to blood-related complications such as anaemia, thrombocytopenia, and coagulopathies, which significantly impact patient health. The review explores the prevalence, causes, and clinical effects of these conditions. It also examines the indications, safety measures, and challenges associated with blood transfusion therapy in this patient group. A key focus is the complex interaction between blood transfusions and the immune system of HIV-infected individuals, including potential immunomodulatory effects, immune activation, and impact on disease progression. The paper synthesises current evidence to identify clinical outcomes, challenges, and controversies, advocating for optimised transfusion practices tailored to the unique immunological needs of HIV patients.
Many people living with HIV suffer from blood-related disorders, and blood transfusions are a common treatment. This research helps medical professionals understand how these transfusions affect the immune system and overall health of HIV patients. It aims to guide better, safer treatment decisions, ultimately improving the well-being and care of individuals living with HIV.
This paper is a comprehensive review of existing knowledge, aiming to inform clinical decision-making and highlight areas for future research in HIV patient care. It does not indicate a direct commercialisation pathway for a specific product or service, but rather contributes to the evidence base for optimising medical practices.
AI-generated from the published abstract. Always read the original work before citing.
HIV infection presents multifaceted challenges, particularly in managing hematologic complications that significantly impact patient well-being and prognosis. Hematologic manifestations such as anemia, thrombocytopenia, and coagulopathies are prevalent in individuals living with HIV, necessitating meticulous attention and specialized care. Among the array of interventions, blood transfusions play a pivotal role in addressing these hematologic complications. However, the complexities surrounding blood transfusion strategies in the context of HIV extend beyond mere hematologic support and delve into intricate immunological considerations. This paper aims to elucidate the nuanced landscape of hematologic support in HIV patients, focusing specifically on blood transfusion strategies and their immunological implications. The review encompasses an in-depth analysis of hematologic abnormalities commonly encountered in HIV, exploring the prevalence, etiology, and clinical impact of anemia, thrombocytopenia, and coagulopathies. Additionally, it examines the indications, safety measures, and challenges associated with blood transfusion therapy in this population. Furthermore, the paper delineates the intricate interplay between blood transfusions and the immunological milieu of HIV-infected individuals. It explores the immunomodulatory effects of transfusions, potential immune activation, and the impact on disease progression, while also addressing concerns regarding alloimmunization and the modulation of immune responses posttransfusion. By synthesizing current evidence and insights, this paper delineates the clinical outcomes, challenges, and controversies surrounding blood transfusion strategies in HIV care. It underscores the need for optimized transfusion practices tailored to the unique immunological landscape of HIV patients and highlights avenues for future research and advancements in clinical practice. In conclusion, this paper serves as a comprehensive resource elucidating hematologic support through blood transfusion strategies in HIV patients, providing a foundation for informed decision-making and paving the way for enhanced care paradigms in the management of hematologic complications in HIV. Keywords: Hematologic Support, HIV, Patients and Blood Transfusion
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.59298/nijbas/2023/1.2.11000
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
